Evidence map›Paper›PMID 16354592›Full record

ArticleNeoplasia (New York, N.Y.)2005

Uroplakin Ib gene transcription in urothelial tumor cells is regulated by CpG methylation.

Prue Cowled, Irene Kanter, Lefta Leonardos, Paul Jackson

Open access · goldAbstract readComparative Study
In one paragraph

Article in Neoplasia (New York, N.Y.), 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Prue CowledDepartment of Surgery, The University of Adelaide, The Queen Elizabeth Hospital, Woodville, South Australia, Australia. prue.cowled@adelaide.edu.au
Irene Kanter
Lefta Leonardos
Paul Jackson
Queen Elizabeth Hospital · AUPrince of Wales Hospital · AUUniversity of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Uroplakin Ib is a structural protein on the surface of urothelial cells. Levels of uroplakin Ib mRNA are dramatically reduced or absent in many transitional cell carcinomas, but the molecular mechanisms responsible remain undetermined. Previously, we showed that loss of uroplakin Ib expression correlated with CpG methylation of Sp1/NFkappaB-binding motifs within the proximal promoter. In this study, we show that reporter activity was completely blocked by the methylation of three CpG pairs in this promoter region. Gel shift analysis using purified proteins or nuclear extracts showed that Sp1 and NFkappaB bound to motifs encompassing two of the three CpG pairs. Interestingly, the methylation of these two CpG sites did not prevent the binding of proteins to the promoter in gel shift analyses. Additionally, mutation of these two CpGs did not affect reporter activity, but mutation of 6-bp fragment spanning each CpG partially inhibited reporter activity, suggesting that these sites were functional. A requirement for both Sp1 and NFkappaB in regulating reporter activity was confirmed in transfection experiments using plasmids expressing individual proteins. Our data suggest that the methylation of specific CpG sites can silence the uroplakin Ib promoter, at least in part, by blocking the binding of Sp1 and NFkappaB, although other factors may be involved.

Indexed as

CpG IslandsDNA MethylationGene Expression Regulation, NeoplasticBase SequenceCells, CulturedChloramphenicol O-AcetyltransferaseElectrophoretic Mobility Shift AssayHumansLuciferasesMembrane GlycoproteinsMolecular Sequence DataMutagenesis, Site-DirectedNF-kappa BPromoter Regions, GeneticReverse Transcriptase Polymerase Chain ReactionSp1 Transcription FactorChloramphenicol O-AcetyltransferaseLuciferasesMembrane GlycoproteinsNF-kappa BSp1 Transcription FactorUPK1B protein, humanUroplakin Ib

Identifiers

PMID16354592
PMCPMC1501173
OpenAlexW2047001809

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.